Content uploaded by Elizabeth M Mathew
Author content
All content in this area was uploaded by Elizabeth M Mathew on Feb 23, 2014
Content may be subject to copyright.
African Journal of Pharmacy and Pharmacology Vol. 5(2), pp. 259-264, February 2011
Available online http://www.academicjournals.org/ajpp
DOI: 10.5897/AJMR11.006
ISSN 1996-0816 ©2011 Academic Journals
Full Length Research Paper
Clinical manifestation, effects, diagnosis, monitoring of
carbon monoxide poisoning and toxicity
Kingston Rajiah1* and Elizabeth Mampally Mathew2
1International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000 Kuala Lumpur, Malaysia.
2Mallige College of Pharmacy, No 71, Silvepura, Bangalore, 560090 Karnataka, India.
Accepted 7 January, 2011
Carbon monoxide is a product of incomplete combustion of organic matter with insufficient oxygen
supply to enable complete oxidation to carbon dioxide (CO2) and is often produced in domestic or
industrial settings. In this study the clinical manifestation, effects, diagnosis and toxicity of carbon
monoxide poisoning were reviewed. Research suggests that the intracellular uptake of carbon
monoxide is an important mechanism for neurologic damage. As a result upon the review of many
articles and research journals, it is identified that carbon monoxide may be quantitated in blood using
spectrophotometric methods or chromatographic techniques in order to confirm the diagnosis of
poisoning in hospitalized victims or to assist in the forensic investigation of a case of fatal exposure. A
brain computed tomography (CT) scan may be normal in early stages or show signs of cerebral edema.
Public education on the safe operation of appliances, heaters, fireplaces and internal combustion
engines is required for prevention of CO poisoning. Carbon monoxide detectors with alarms can
improve home safety and their use is recommended by various safety organizations.
Key words: Carbon monoxide, toxicity, hemoglobin.
INTRODUCTION
Carbon monoxide has been unknowingly used by
humans since prehistoric times, for the smelting of iron
and other metallic ores. The gas was used for executions
by the Greek and Romans in “classical antiquity”, and
was first described by the Spanish doctor Arnaldus de
Villa Nova in the 11th century. In 1776, the French
chemist de Lassone produced CO by heating zinc oxide
with coke (fuel), but mistakenly concluded that the
gaseous product was hydrogen as it burned with a blue
flame. The gas was identified as a compound containing
carbon and oxygen by the Scottish chemist William
Cumberland Cruikshank in the year 1800. Its toxic
properties on dogs were thoroughly investigated by
Claude Bernard around 1846 (Cobb and Etzl, 1991).
SOURCES OF CARBON MONOXIDE
The human body produces carbon monoxide as a
*Corresponding author. E-mail: kingrajiah@gmail.com.
by product of hemoglobin degradation, resulting in
baseline carboxyhemoglobin (COHb) saturation of 1 to
3% in non-smokers and 10 to 15% amongst heavy
smokers. A smoker is exposed to 400 to 500 ppm of CO
while actively smoking (Cobb and Etzl, 1991). According
to ten years review of carbon monoxide related deaths,
more than half of unintentional deaths were caused by
motor vehicle exhaust (Cobb and Etzl, 1991). Burning of
charcoal, wood, kerosene, or natural gas for heating and
cooking also produces carbon monoxide (Raub et al.,
2000). In army setting, poisoning is usually seen in high-
altitude areas where unwary soldiers often sleep in
closed tents with burning bhukharis (charcoal/kerosene)
kept inside (Grace and Platt, 1981). Carbon monoxide
can occur in the presence of other factors, complicating
its management. It is a major contributor in thousands of
smoke inhalation deaths that occur each year.
People, who work with methylene chloride as paint
stripper, can be poisoned because the fumes are readily
absorbed and converted to CO in the liver (Meredith and
Vale, 1988). In such cases, peak COHb levels may be
delayed and prolonged because of on going production of
CO from liver.
260 Afr. J. Pharm. Pharmacol.
TOXICITY OF CO
The amount of CO absorbed by the body depends on
minute ventilation, duration of exposure and concen-
tration of CO in the environment. Carbon monoxide
quickly binds with hemoglobin with an affinity greater than
that of oxygen to form COHb. The resulting decrease in
arterial oxygen content and shift of the oxyhemoglobin
dissociation curve to the left explains the acute hypoxic
symptoms (primarily neurologic and cardiac) seen in
patients with acute poisoning (Mehta et al., 2001). But the
toxic effects of CO cannot be explained by these
processes alone, as COHb levels do not correlate well
with symptoms, outcomes or the phenomenon of delayed
neurologic sequelae (Ely et al., 1995). Research
suggests that the intracellular uptake of carbon monoxide
is an important mechanism for neurologic damage. When
carbon monoxide binds to cytochrome oxidase, it causes
mitochondrial dysfunction resulting into oxidative stress
related damage (Prockop and Chichkova, 2007). The
release of nitric oxide from platelets and endothelial cells,
which forms the free radical peroxynitrite, can further
inactivate mitochondrial enzymes and damage the
vascular endothelium of the brain (Myers and Synder,
1985). The end result is lipid peroxidation of the brain,
which starts during recovery from carbon monoxide
poisoning. With reperfusion of the brain, leukocyte
adhesion and the subsequent release of destructive
enzymes and excitatory amino acids all amplify the initial
oxidative injury (Burney, 1982). The net result is cognitive
defects, particularly in memory and learning with
movement disorders that may not appear for days
following the initial poisoning.
Carbon monoxide exposure has an especially dele-
terious effect on pregnant women, because of the greater
sensitivity of the foetus to the harmful effects of the gas.
The final COHb levels in the foetus significantly exceed
the level of the mother (Remick and Miles, 1997). The
excessive left shift of foetal COHb curve makes tissue
hypoxia more severe by releasing less oxygen to the
foetal tissues (Sato et al., 1990). Although the terato-
genicity of CO is controversial, the risk of foetal injury is
increased (Remick and Miles, 1997; Sato et al., 1990).
Once CO exposure is discontinued, dissociation of COHb
occurs and CO is excreted through the lungs. At
atmospheric pressure, the COHb half-life is 4 to 6 h
which decreases to 40 to 80 min on breathing 100%
oxygen.
Effects of CO
Patients can successfully recover from acute CO poison-
ing only to return, days later with serious neurological
problems, ranging from subtle cognitive deficits (apparent
on neuropsychological testing) to gross incapacitating
movement disorders, resulting from carbon monoxide’s
predilection for basal ganglia (Tibbles, 1996). Within
a day of high CO exposure, neuroimaging can show
decreased density in the central white matter and globus
pallidus. Autopsies have shown involvement of cerebral
cortex, hippocampus, cerebellum, and substantia nigra.
Neurologic sequelae may be evident immediately or may
occur after a lucid interval of up to three weeks. The
incidence of such sequelae can be as high as 40% (for
memory impairment), and they may persist for more than
a year. Children may present with behavioral or learning
problems, while the elderly appear to be more
susceptible to devastating consequences (Burney, 1982;
Sato et al., 1990).
The development of neurologic sequelae cannot be
reliably predicted. However, most cases are associated
with loss of consciousness in the acute phase of
intoxication (Hark and Kennedy, 1998). The standard CO
neuropsychological screen battery helps in objective
evaluation of such patients.
Severe CO poisoning
The symptoms of low level chronic CO intoxication are
non-specific, and unlikely to arouse suspicion of CO as
the cause. It can also exacerbate the preexisting
diseases like ischaemic heart disease or dementia (Sato
et al., 1990). Patients present with bizarre behavioural
abnormalities declining intellect, memory disturbances,
chronic cough or diarrhoea. The condition is often
misdiagnosed as chronic fatigue syndrome, a viral,
bacterial, pulmonary, gastrointestinal infection or immune
deficiency. Patients may occasionally present with
polycythemia or increased hematocrit. COHb is usually
not excessively elevated.
Clinical manifestations
Clinical manifestations of acute CO poisoning can be
vague and may closely mimic various nonspecific viral
illnesses. CO poisoning usually affects many people at
the same time. The acute symptoms of CO poisoning are
reflected in the susceptibility of the brain and heart.
Initially, patients may complain of headache, dizziness,
nausea, emotional liability, confusion, impaired judgment,
clumsiness and syncope (Ely et al., 1995; Myers and
Synder, 1985; Burney, 1982). Vomiting may be the only
presenting symptom in infants and may be misdiagnosed
as gastroenteritis. Coma or seizures can occur in patients
with prolonged CO exposure (Hark and Kennedy, 1998).
Elderly patients, especially those with coronary artery
disease, may have accompanying myocardial ischaemia,
which may result in frank myocardial infarction (Sato et
al., 1990). Prolonged exposures resulting in coma or
altered mental status may be accompanied by retinal
hemorrhages and lactic acidosis (Ely et al., 1995).
Myonecrosis can occur but it rarely leads to
compartment syndrome or renal failure. Cherry-red skin
color associated with severe carbon monoxide
Raijiah and Mathew 261
Table 1. Comparison of clinical features between Mehta et al and Pooled data Ely et al.
Clinical features Mehta et al. (n = 25)%
of patient
Pooled data (Ely et al., Myers et al.,
and Burney) (n = 196)% of patient
Drowsiness and/ or confusion 48 43
Coma 24 6
Hemiparesis 24 6
Seizures 12 -
Angina pectoris 8 9
Dyspnoea/ tachypnoea 80 40
Tachycardia 64 -
Cherry red skin 24 -
Table 2. Levels of COHb and clinical manifestations
Concentration (%) Symptoms
35 ppm (0.0035) Headache and dizziness within six to eight hours of constant exposure.
100 ppm (0.01) Slight headache in two to 3 h.
200 ppm (0.02) Slight headache within two to three hours; loss of judgment.
400 ppm (0.04) Frontal headache within one to 2 h.
800 ppm (0.08) Dizziness, nausea, and convulsions within 45 min; insensible within 2 h.
1,600 ppm (0.16) Headache, tachycardia, dizziness, and nausea within 20 min; death in less than 2 h.
3,200 ppm (0.32) Headache, dizziness and nausea in five to ten minutes. Death within 30 min.
6,400 ppm (0.64) Headache and dizziness in one to two minutes. Convulsions, respiratory arrest,
and death in less than 20 min.
12,800 ppm (1.28) Unconsciousness after 2 to 3 breaths. Death in less than 3 min.
poisoning is seen in only 2 to 3% of symptomatic cases
(Burney, 1982). Various clinical features for evaluation of
such cases are shown in Table 1.
Skin may develop erythematous lesions and bullae
especially over bony prominences. Severe poisoning
often leads to hypotension and pulmonary edema with
the former is the most reliable marker of overall prognosis.
The acute effects produced by carbon monoxide in
relation to ambient concentration in parts per million are
listed in Table 2.
Diagnosis
Physicians should be alert for the symptoms of carbon
monoxide poisoning, especially during the winter, when
risk of continued prolonged exposures may be greater.
Patients who present with flu-like symptoms (that is
headache, nausea, and dizziness) should be questioned
about the use of gas or oil based heating appliances at
home or work. The same symptoms occurring in
housemates are also a warning sign of environmental
exposure. Criteria for admission and prolonged
observation of such cases are shown in Table 3. A hand
held breath analyzer can be used to quickly rule out
carbon monoxide poisoning. However, the incidental
presence of ethanol can result in a false-positive reading.
Comatose patients can be monitored for rhabdomyolysis
by measuring creatine kinase (CK) levels. A brain
computed tomography (CT) scan may be normal in early
stages or show signs of cerebral oedema. Subsequently
CT may show symmetrical bilateral hypodensities of the
basal ganglia, particularly of the globus pallidus and
substantia nigra. The other abnormalities may be
subcortical white matter hypodensities, cerebral cortical
lesions, hippocampal lesions, and loss of gray-white
differentiation.
The electro encephalogram usually demonstrates
diffuse slowing which is of little prognostic value. Single
photon emission computed tomography (SPECT) has
also been used in CO poisoning cases.
Detection in biological specimens
Carbon monoxide may be quantitated in blood using
spectrophotometric methods or chromatographic techni-ques. This
is done in order to confirm a diagnosis of poisoning in hospitalized
victims or to assist in the forensic investigation of a case of fatal
exposure.
Carboxyhemoglobin blood saturations may range up to 8 to 10%
in heavy smokers or persons extensively exposed to automotive
exhaust gases. In symptomatic poisoned patients they are often in
the 10 to 30% range, while persons who succumb may have
postmortem blood levels of 30 to 90% (Sato et al., 1990).
262 Afr. J. Pharm. Pharmacol.
Table 3. Criteria for admission and prolonged observation.
1. Loss of consciousness.
2. Neurological deficit at any time.
3. Clinical or electrocardiographic signs of cardiac compromise.
4. Metabolic acidosis.
5. Abnormal chest radiograph.
6. COHb level >25%,COHb level >15% with a history of cardiac disease
or > 10% in a pregnant patient.
7. PO<60 mm Hg.
Table 4. Indications for HBO therapy in CO poisoning.
1. Comatose patients.
2. Any period of unconsciousness.
3. Any abnormal score on the Carbon monoxide neuropsychological screening battery.
4. Patients with COHb levels >40%.
5. Cardiovascular involvement (chest pain, ECG changes arrhythmias).
6. History of ischaemic heart disease and COHb levels >15%.
7. Pregnant patients with COHb levels >15%.
8. Patients who do not respond to 100% oxygen after 4 to 6 h.
9. Patients with recurrent symptoms up to three weeks after exposure.
TREATMENT
The initial treatment of patients with symptomatic carbon
monoxide poisoning is relatively straightforward. Non-re-
breather mask supplies 100% oxygen to quickly clear
COHb from the blood and this therapy reduces the half-
life of COHb from about 4 to 5 h to 1 h (Grace and Platt,
1981). Oxygenation at a peripheral setup can be given
with a simple oro-nasal plastic mask at a flow rate of 6 to
10 litres/minute which gives oxygen concentration of
about 35 to 50%. Oxygen delivery with face mask with
reservoir corticosteroids, mannitol, hypothermia and
hyperventilation has been recommended in serious cases
of CO poisoning but their benefit has not been proved.
HBO therapy
Hyperbaric oxygen therapy (HBO) for the treatment of
carbon monoxide (CO) poisoning was first discussed by
Haldane in the 1890s and was first used in the 1960s
(Smith, 1962). At the time, CO toxicity was thought to
result entirely from the relative anemia and hypoxia
imposed by the formation of carboxyhemoglobin (CO-
Hgb) (Haldane, 1972). We now know that the
pathophysiology of CO poisoning is much more complex
and involves direct toxicity at the cellular level (Kao and
Nanagas, 2005). Mechanisms and potential treatments
for CO poisoning are an area of active basic science and
animal research. Clinically intriguing is a syndrome of
apparent recovery followed approximately 2 weeks later
by behavioral and/or neurologic deterioration. This is
known as delayed neurologic sequelae (DNS) and it may
be debilitating and permanent (Thom and Keim, 1989;
Min, 1983; Myers et al., 1985; Prockop; 2005). The exact
cause and incidence of DNS remains elusive as does of
a precise definition. Indications for HBO therapy in CO
poisoning is given in Table 4.
Chem-optical (gel cell) technology
Chem-optical technology (or gel cell or biomimetic
technology) alarms use a type of sensor that simulates
haemoglobin in the blood.
Electrochemical alarm
Electrochemical alarms work by converting the carbon
monoxide electrochemically to carbon dioxide, which
generates an electrical current that is taken as a measure
of the gas concentration. Electrochemical alarms are
usually powered by a battery lasting about five years.
Semiconductor technology
These alarms use semiconductors or tin dioxide
technology to detect carbon monoxide levels. Unlike the
alarms above, semiconductor detector alarms do not
require any replacement sensors. The British Standards
Institute (BSI) is a national standards body, responsible
for ensuring products meet certain agreed standards of
safety. BSI standard BS7860 is the one for monitors that
detect carbon monoxide at levels well before they
become dangerous for humans (Tibbles, 1996). Preven-
tion requires public education on the safe operation of
appliances, heaters, fireplaces and internal combustion
engines. Increased awareness amongst soldiers posted
to cold/high altitude areas about the dangers of using
sigris and bhukharis in enclosed places like
tents/bashas/barracks/rooms will go a long way in
preventing CO poisoning and deaths.
Burned victims, with evidence of smoke inhalation from
an enclosed fire, should undergo testing for COHb levels.
During winters, CO poisoning should be suspected in
patients presenting with flu-like symptoms (for example
headache, dizziness and nausea), which they may not
attribute to a faulty furnace or other heating sources.
Carbon monoxide detectors with alarms can improve
home safety and their use is recommended by various
safety organizations.
PREVENTION
Carbon monoxide detectors are available from most local
hardware. They can provide an audible high-pitched
alarm when high levels of carbon monoxide are detected
or provide an alarm plus a digital display of the
concentration of carbon monoxide detected in units of
'parts per million' (ppm). Three types of carbon monoxide
detectors are available.
CONCLUSIONS
Carbon monoxide poisoning is a multi-system condition
and can cause a confusing constellation of clinical
features, precipitating presentation to general practi-
tioners, accident and emergency departments, acute care
physicians, general surgeons, neurologists and even
psychiatrists. With increasing specialization within the
medical profession the diagnosis may be missed by the
specialist who fails to recognize the significance of
pathology outside his or her own area of interest. The
benefits of prompt diagnosis are threefold. Firstly,
recommended therapy, in the form of 100% normobaric
oxygen in all cases and hyperbaric oxygen in cases of life
threatening poisoning can be instigated.
Secondly, as illustrated by this case, unnecessary
expensive and painful investigations can be avoided.
Thirdly, and perhaps most importantly, the dire cones-
quences of discharging a patient home to, or allowing
others access to a potentially fatal environment can be
avoided.
Raijiah and Mathew 263
REFERENCES
Cobb N, Etzl RA (1991). Unintentional carbon monoxide related deaths
in United States. JAMA., 266: 659-63.
Hark IK, Kennedy PGE (1998). Neurological manifestation of carbon
monoxide poisoning. Postgrad Med. J., 64: 213-216.
Raub JA, Mathieu-Nolf, Hampson NB, Thom SR (2000). Carbon
monoxide poisoning-a public health perspective. Toxicol., 145: 1-14
Grace TW, Platt FW (1981). Sub-acute poisoning. JAMA., 246: 1698-
700.
Meredith T, Vale A (1988). Carbon monoxide poisoning. BMJ., 296: 77-
79.
Mehta SR, Niyogi M, Kasthuri AS (2001). Carbon monoxide poisoning.
J. Ass. Phy. India., 49: 622-625.
Ely EW, Moorehead B, Haponik EF (1995). Warehouse workers’
headache: emergency evaluation and management of 30 patients
with carbon monoxide poisoning. Am. J. Med., 98:145-155.
Prockop LD, Chichkova RI (Nov 2007). "Carbon monoxide intoxication:
an updated review". J. Neurol. Sci., 262(1-2): 122–130
Myers RAM, Synder SK (1985). Subacute sequelae of carbon monoxide
poisoning. Ann. Emerg. Med., 14: 1163-1167.
Burney RE (1982). Mass carbon monoxide poisoning – 184 victims. Ann.
Emerg. Med., 11: 394-399.
Remick R, Miles J (1997). Carbon monoxide poisoning: neurological
and psychiatric sequelae. Can. Med. Asso. J., 117: 654-656.
Sato K, Tamaki K, Hattori H (1990). Determination of total hemoglobin
in forensic blood samples with special reference to
carboxyhemoglobin analysis. For. Sci. Int., 48: 89-96.
Tibbles PM (1996). Hyperbaric oxygen therapy. N. Eng. J. Med., 334:
1642-1648.
Smith G (1962). The treatment of carbon monoxide poisoning with
oxygen at two atmospheres absolute. Ann Occup. Hyg., 5: 259-263.
Haldane J (1972). Medicolegal contributions of historical interest. The
action of carbonic oxide on man. Forensic Sci., 1: 451-483.
Kao LW, Nanagas KA (2005). Carbon monoxide poisoning. Med Clin
North Am., 89: 1161-1194.
Thom SR, Keim LW (1989). Carbon monoxide poisoning: a review.
Epidemiology, pathophysiology, clinical findings, and treatment
options including hyperbaric oxygen therapy. J. Toxicol. Clin. Toxicol.,
27: 141-156.
Min SKA (1983). Brain syndrome associated with delayed
neuropsychiatric sequelae following acute carbon monoxide
intoxication. Acta Psychiatr Scand. 1986., 73: 80-86.
Myers RA, Snyder SK, Emhoff TA (1985). Subacute sequelae of carbon
monoxide poisoning. Ann. Emerg. Med., 14: 1163-1167.
Prockop LD (2005). Carbon monoxide brain toxicity: clinical, magnetic
resonance imaging, magnetic resonance spectroscopy, and
neuropsychological effects in 9 people. J. Neuroimaging, 15: 144–
149.